GENEVA–(BUSINESS WIRE)–Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
GENEVA–(BUSINESS WIRE)–Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
Uncategorized
Gene therapies may help patients maintain vision in AMD long term
WAIKOLOA, Hawaii — The recent progress and future development of gene therapy could help patients with wet age-related macular degeneration maintain vision, according to a speaker at Retina 2026.Allen C. Ho, MD, of Wills Eye Hospital, said gene therapy…
Uncategorized
Ametek acquires LKC Technologies, maker of RetEval
Editor’s note: This is a developing news story. Please check back soon for updates.LKC Technologies, maker of the RetEval handheld electroretinography device, has been acquired by Ametek, according to a press release.“Becoming part of Ametek is a power…
Uncategorized
National Vision Announces Participation in Upcoming Investor Conferences
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company will participate in the following upcoming conferences: Citi 2026 Global Consumer & Retail Conference D…
Uncategorized
First Patient Treated in TECLens First-in-Human Clinical Study of Revolutionary Non-Invasive Vision Correction Technology
STAMFORD, Conn–(BUSINESS WIRE)–TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today the treatment of the initial patient for its first-in-human clinical trial evaluating the company’s groundbreaking quantitative corneal …